Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,744 INR | +4.56% | -1.68% | +7.57% |
Sales 2024 | 34.84B 419M | Sales 2025 * | 40.56B 488M | Capitalization | 259B 3.12B |
---|---|---|---|---|---|
Net income 2024 | 5.53B 66.49M | Net income 2025 * | 7.02B 84.51M | EV / Sales 2024 | 7.35 x |
Net Debt 2024 * | 1.32B 15.87M | Net cash position 2025 * | 5.26B 63.25M | EV / Sales 2025 * | 6.25 x |
P/E ratio 2024 |
47.3
x | P/E ratio 2025 * |
37.1
x | Employees | 5,095 |
Yield 2024 * |
0.67% | Yield 2025 * |
0.95% | Free-Float | 45.82% |
Latest transcript on J. B. Chemicals & Pharmaceuticals Limited
1 day | +4.73% | ||
1 week | -1.68% | ||
Current month | -8.23% | ||
1 month | -8.34% | ||
3 months | +6.27% | ||
6 months | +25.68% | ||
Current year | +7.57% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-10-04 | |
Bharat Dhanani
COO | Chief Operating Officer | - | - |
Sujay Rajhans
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-08-30 | |
Akshay Tanna
BRD | Director/Board Member | 40 | Nov. 06 |
Gaurav Trehan
BRD | Director/Board Member | 48 | 21-02-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.20% | - | |
0.00% | 112 M€ | +4.59% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 1,744 | +4.56% | 8 156 |
24-05-24 | 1,668 | -0.61% | 5,050 |
24-05-23 | 1,679 | -1.35% | 5,100 |
24-05-22 | 1,702 | -4.24% | 8,625 |
24-05-21 | 1,777 | -3.45% | 3,253 |
Delayed Quote Bombay S.E., May 27, 2024 at 01:02 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.57% | 3.12B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- JBCHEPHARM Stock